Cargando…

Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan

INTRODUCTION: Diagnostic testing is important in determining appropriate treatment for individuals with lung cancer. In 2018, testing of five biomarkers (EGFR, ALK, ROS1, BRAF, programmed cell death-ligand 1 [PD-L1]) was approved in Japan. Information is lacking regarding real-world testing patterns...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yatabe, Yasushi, Yoshiki, Yasumasa, Matsumura, Koichi, Togo, Kanae, Kikkawa, Hironori, Iadeluca, Laura, Li, Benjamin, Nishio, Kazuto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474388/ https://www.ncbi.nlm.nih.gov/pubmed/34589999 http://dx.doi.org/10.1016/j.jtocrr.2020.100136

Ejemplares similares

Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan
por: Takahashi, Toshiaki, et al.
Publicado: (2023)

Real-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan
por: Sawaki, Masataka, et al.
Publicado: (2023)

Targeting MET Amplification as a New Oncogenic Driver
por: Kawakami, Hisato, et al.
Publicado: (2014)

Real world data and data science in medical research: present and future
por: Togo, Kanae, et al.
Publicado: (2022)

Real‐world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer
por: Goto, Yasushi, et al.
Publicado: (2023)

Lung cancer biomarker tests: the history and perspective in Japan
por: Motoi, Noriko, et al.
Publicado: (2020)

Oncogenic drivers and mitochondrial dependency
por: Alvarez-Calderon, Francesca, et al.
Publicado: (2015)

Current status of antimicrobial prophylaxis during extracorporeal membrane oxygenation in Japan: a national survey
por: Hara, Yoshitaka, et al.
Publicado: (2021)

Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study
por: Akazawa, Manabu, et al.
Publicado: (2019)

Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan
por: Winburn, Ian, et al.
Publicado: (2019)

1497. Epidemiology of RSV infection in Japan: A nationwide claims database analysis
por: Kobayashi, Yasuhiro, et al.
Publicado: (2020)

Epidemiology of respiratory syncytial virus in Japan: A nationwide claims database analysis
por: Kobayashi, Yasuhiro, et al.
Publicado: (2021)

Physician and patient perceptions of surgical procedures for osteoarthritis of the knee in the United States, Europe, and Japan: results of a real-world study
por: Fukui, N, et al.
Publicado: (2022)

Oncogenic driver mutations in lung cancer
por: Luo, Susan Y, et al.
Publicado: (2013)

Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan
por: Suzuki, Shiho, et al.
Publicado: (2023)

Real-world effects of once-daily inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) and long-acting muscarinic antagonist (umeclidinium) on lung function tests of asthma patients in Japan
por: Umeda, Akira, et al.
Publicado: (2023)

Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan
por: Hiramatsu, Katsutoshi, et al.
Publicado: (2021)

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2023)

Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal
por: Ando, Yukio, et al.
Publicado: (2023)

Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study
por: Waterhouse, David, et al.
Publicado: (2021)

The long tail of oncogenic drivers in prostate cancer
por: Armenia, Joshua, et al.
Publicado: (2018)

Oncogenic Viruses as Entropic Drivers of Cancer Evolution
por: Tempera, Italo, et al.
Publicado: (2021)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

New Era for Next-Generation Sequencing in Japan
por: Takeda, Masayuki, et al.
Publicado: (2019)

Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study
por: Hashimoto, Shu, et al.
Publicado: (2023)

Clinicians’ Real World Perceptions of Pre-Nephrectomy Diagnostic Biopsy Performance as a Driver of Reduction in Unnecessary Surgeries in Renal Tumors
por: Fahy, Kristin, et al.
Publicado: (2015)

Real‐world evidence on disseminated intravascular coagulation from Japan
por: Hisamune, Ryo, et al.
Publicado: (2023)

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
por: Naramura, Mayumi, et al.
Publicado: (2011)

Bcl-x(L) is an oncogenic driver in colorectal cancer
por: Scherr, Anna-Lena, et al.
Publicado: (2016)

Ribosomal proteins: a novel class of oncogenic drivers
por: Sulima, Sergey O., et al.
Publicado: (2017)

Concomitant Pathogenic Mutations and Fusions of Driver Oncogenes in Tumors
por: Zhang, Runjiao, et al.
Publicado: (2021)

The current state and future of internet technology-based hypertension management in Japan
por: Yatabe, Junichi, et al.
Publicado: (2020)

Real‑world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real‑world data project
por: Shimoyama, Rai, et al.
Publicado: (2023)

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma
por: Park, Jangchul, et al.
Publicado: (2016)

Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer
por: Suda, Kenichi, et al.
Publicado: (2015)

Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan
por: Kashihara, Naoki, et al.
Publicado: (2019)

Real‐world etiologies and treatments of pediatric short bowel syndrome in Japan
por: Tazuke, Yuko, et al.
Publicado: (2022)

Assessment of real-world application of advanced prostate cancer management in Japan
por: Aragon-Ching, Jeanny B.
Publicado: (2022)

Real‐world results with IgPro20 for hypo‐ or agammaglobulinemia in Japan
por: Imai, Kohsuke, et al.
Publicado: (2022)

Strategies to Address Current Challenges in Real-World Evidence Generation in Japan
por: Laurent, Thomas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lrb9iu4k5oec14uujscg6rs1e3